2008EULAR/PRITO/PRES 过敏性紫癜、儿童结节性多动脉炎、儿童韦格纳肉芽肿、儿童多发性大动脉炎标准(第一部分):最终分类标准

发布日期:
2010-04-13
英文标题:
EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part I: Overall methodology and clinical characterisation
出处:
Ann Rheum Dis. 2010 May;69(5):790-7
摘要:

该标准还有第二部分:

请见>>过敏性紫癜、儿童结节性多动脉炎、儿童韦格纳肉芽肿、儿童多发性大动脉炎标准(第二部分):分类标准

Abstract

OBJECTIVES:

To report methodology and overall clinical, laboratory and radiographic characteristics for Henoch-Schönleinpurpura (HSP), childhood polyarteritis nodosa (c-PAN), c-Wegener granulomatosis (c-WG) and c-Takayasu arteritis (c-TA) classification criteria.

METHODS:

The preliminary Vienna 2005 consensus conference, which proposed preliminary criteria for paediatric vasculitides, was followed by a EULAR/PRINTO/PRES - supported validation project divided into three main steps. Step 1: retrospective/prospective web-data collection for HSP, c-PAN, c-WG and c-TA, with age at diagnosis <or=18 years. Step 2: blinded classification by consensus panel of a subgroup of 280 cases (128 difficult cases, 152 randomly selected) enabling expert diagnostic verification. Step 3: Ankara 2008 Consensus Conference and statistical evaluation (sensitivity, specificity, area under the curve, kappa-agreement) using as 'gold standard' the final consensus classification or original treating physician diagnosis.

RESULTS:

A total of 1183/1398 (85%) samples collected were available for analysis: 827 HSP, 150 c-PAN, 60 c-WG, 87 c-TA and 59 c-other. Prevalence, signs/symptoms, laboratory, biopsy and imaging reports were consistent with the clinical picture of the four c-vasculitides. A representative subgroup of 280 patients was blinded to the treating physician diagnosis and classified by a consensus panel, with a kappa-agreement of 0.96 for HSP (95% CI 0.84 to 1), 0.88 for c-WG (95% CI 0.76 to 0.99), 0.84 for c-TA (95% CI 0.73 to 0.96) and 0.73 for c-PAN (95% CI 0.62 to 0.84), with an overall kappa of 0.79 (95% CI 0.73 to 0.84).

CONCLUSION:

EULAR/PRINTO/PRES propose validated classification criteria for HSP, c-PAN, c-WG and c-TA, with substantial/almost perfect agreement with the final consensus classification or original treating physician diagnosis.

展开

部分内容仅可在
临床指南app 查看下载

阅读免费指南
发送到邮箱

收藏

分享

评论
提交评论
15188319475YY
2015.03.01
回复
此类疾病的诊断标准已有,希望出疾病的疗效评价标准。
/ 没有更多了 /
上传者信息
lkself
于2013-02-04上传
编者信息
儿童风湿病国际试验组织

儿童风湿病试验组织(PRINTO)是一个非盈利性非政府组织,国际研究网络于1996年由Alberto Martini和Nicolino Ruperto成立,最初包括14个欧洲国家(现在超过50个,全球超过350中心)。报告儿童风湿病多中心国际临床研究

置顶